fig6

Figure 6. Increased expression of EEF1A2, BCL10 and phosphorylated NFκB in the LCBM. (A) RT-qPCR was used to determine the relative expression levels of EEF1A2, Cdc42, and E-cadherin genes in samples from 21 patients with LCBM and 21 patients with LC. *P < 0.05; ***P < 0.001; ns indicates no significant difference compared to the LC group. (B and C) Western blot analysis of EEF1A2, BCL10, and phosphorylated NFκB (phospho-NFκB) in tumor samples from five LC patients and five LCBM patients. *P < 0.05; ***P < 0.001; ****P < 0.0001.